IHS Chemical Week

Regions :: Western Europe :: U.K.

Pfizer makes final offer for AstraZeneca, will walk away if offer not accepted

11:13 AM MDT | May 19, 2014 | Natasha Alperowicz

Pfizer said on Sunday that it has raised its offer for AstraZeneca to £69 billion ($116 billion), and said it would walk away if AstraZeneca does not accept the offer. The improved proposal is final and cannot be increased, Pfizer says. AstraZeneca shareholders would receive, for each AstraZeneca share, 1.747 shares in the combined entity and 2,476 pence in cash, representing an indicative value of £55.00. On 2 May, AstraZeneca rejected Pfizer's sweetened proposal.   Pfizer says this is an increase of approximately 15% over its 2 May proposal...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa